EPISODE · Oct 16, 2025 · 6 MIN
The Future of Drug Discovery: The 27B AI That Found a New Cancer Immunotherapy Pathway
from Intellectually Curious · host Mike Breault
We explore how a 27‑billion-parameter biology foundation model from the Gemma family generated a testable, context‑dependent hypothesis that boosts MHCI antigen presentation only under a specific immune condition. Through a dual‑context virtual screen, somatassertib (CX4945) was predicted to act as a conditional amplifier and validated experimentally in human neuroendocrine cells, marking a milestone in AI‑driven biology. We discuss the implications for cancer immunotherapy, the future of AI‑assisted discovery, and where to access the preprint, model, and code.Note: This podcast was AI-generated, and sometimes AI can make mistakes. Please double-check any critical information.Sponsored by Embersilk LLC
Embed this episode
What this episode covers
We explore how a 27‑billion-parameter biology foundation model from the Gemma family generated a testable, context‑dependent hypothesis that boosts MHCI antigen presentation only under a specific immune condition. Through a dual‑context virtual screen, somatassertib (CX4945) was predicted to act as a conditional amplifier and validated experimentally in human neuroendocrine cells, marking a milestone in AI‑driven biology. We discuss the implications for cancer immunotherapy, the future of AI‑...
NOW PLAYING
The Future of Drug Discovery: The 27B AI That Found a New Cancer Immunotherapy Pathway
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.